Overview

Erythromycin in Parkinson's Disease

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Gastroparesis (slow stomach emptying) is a common feature of Parkinson's Disease. Levodopa (Sinemet), a common medication for Parkinson's Disease, can make gastroparesis worse. Gastroparesis effects how the levodopa is absorbed and used by the body. This study will explore the possibility of using Erythromycin, a drug commonly used (off label) for gastroparesis, along with levodopa to determine if there is improved levodopa absorption and motor function.
Phase:
N/A
Details
Lead Sponsor:
Virginia Commonwealth University
Treatments:
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Levodopa